Knilonat 150mg Capsule

Product Description

Knilonat 150mg Capsule contains Nilotinib, a tyrosine kinase inhibitor used primarily in the treatment of certain types of leukemia, such as chronic myeloid leukemia (CML). Targeting particular proteins that encourage the development of cancer cells is how nilotinib functions.

If you are taking medication for an infection or have liver, kidney, or heart problems, let your doctor know since there may be interactions. Effective contraception is crucial throughout therapy, and this medication is not advised during pregnancy or lactation.

Brand Name: Knilonat

Composition: Nilotinib

Mechanism of Action:

The BCR-ABL tyrosine kinase, a protein that promotes leukemia cell growth in CML, is specifically inhibited by nilotinib. Nilotinib slows the growth and metastasis of cancer cells by inhibiting this enzyme.

Uses:

Chronic Myeloid Leukemia (Blood Cancer)

Dosage and Administration:

Typically, 300400 mg are taken twice a day, separated by roughly 12 hours. orally on an empty stomach because food can greatly increase the risk of toxicity and drug absorption.

Side Effects:

• Neutropenia
• Anemia
• Thrombocytopenia
• Increasing the risk of infection and bleeding
• Diarrhea
• Nausea
• Fatigue
• Fever
• Dizziness
• Vomiting
• Abdominal pain